ENG and breast carcinoma: To more precisely evaluate ENG staining on stromal fibroblasts and better determine the clinical significance, we employed a larger cohort including 232 breast cancer patients (Table S2) and performed immunohistochemistry with an anti‐ENG antibody (Fig. S1C).